Embedded Files
Intelligence, Analytics and Research
Intelligence, Analytics and Research
If you would like to contribute articles on a regular basis to these publications, do drop us a note at hal@thinkshiftdesign.com.
Global
Global
Singapore
Singapore
Agencies
Agencies
Industry Transformation Maps
Industry Transformation Maps
Sector Focus: Medical Technology
Sector Focus: Medical Technology
The Asia Medical Technology market is expected to grow at a CAGR of 8% and is projected to overtake the EU as the second largest market globally by 2020. Singapore is strategically placed to enable MedTech companies to tap into these regional opportunities. Today, Singapore is home to more than 60 multinational MedTech companies undertaking a range of activities from regional headquarters and manufacturing, to research and development.
High-value MedTech manufacturing base
High-value MedTech manufacturing base
Singapore is a critical manufacturing base producing a diverse range of medical technology products from implantable pacemakers, to contact lenses and life science instruments for global markets. Companies leverage on Singapore’s strong design and engineering capabilities, base of automation suppliers and high quality assurance standards to undertake the manufacturing of high-value medical products.
Innovative R&D ecosystem
Innovative R&D ecosystem
Singapore’s network of top universities, research institutions and innovative start-ups enable MedTech companies to tap a vibrant open innovation ecosystem. With a strong presence of more than 25 R&D centres established by multinational MedTech companies and a local pool of over 220 MedTech start-ups and small-medium enterprises, MedTech companies have increasingly been plugging into this network of innovation, talent and ideas to develop next-generation products and solutions for the region.
Hub for new business model innovation
Hub for new business model innovation
With the shift toward connected devices, Singapore offers companies a strong base to build new business models around big data and patient-centric care. Our base of design consultancies, data analytics research and applied data analytics talent provide companies the capabilities to develop new go-to-market strategies in Asia.
Sector Focus: Pharmaceuticals and Biotechnology
Sector Focus: Pharmaceuticals and Biotechnology
Singapore’s deep base of skilled talent, strong manufacturing capabilities and thriving research ecosystem have drawn pharmaceutical and biotechnology firms to set up here to serve patients from around the globe, and connect with the growing Asian market.
Leading Commercial Hub
Leading Commercial Hub
As a leading biomedical sciences hub at the heart of Asia, Singapore is the choice location for companies to develop and produce new products that better meet Asia’s healthcare needs. Companies benefit from our pro-business environment, infrastructure, talent and innovation ecosystem, as well as our proximity to the rest of Asia. Companies like GlaxoSmithKline, MSD and Roche have based a range of commercial activities, including Supply Chain Management, Regulatory Affairs and Medical Affairs in Singapore.
World-class manufacturing capabilities
World-class manufacturing capabilities
Singapore is a leading location for best-in-class manufacturing plants, where innovative products are launched and produced. Industry leaders like Pfizer, Novartis, Sanofi, AbbVie and Amgen have global manufacturing hubs in Singapore for a wide range of products including Active Pharmaceutical Ingredients, drug products and biologics drug substances. Since 2014, we have also partnered the industry to develop new talent training programmes.
Innovation ecosystem
Innovation ecosystem
Even as drug discovery and development models evolve amid regulatory changes and challenging R&D productivity, our extensive and integrated research ecosystem continues to deliver impact and value to pharmaceutical companies. Here, firms can forge partnerships with key opinion leaders, institutes, emerging biotechs, as well as clinical and contract research organisations to rapidly advance pipeline assets.
Press Releases and Sources
Press Releases and Sources
Page updated
Report abuse